Drug Infusion Systems Market Report
Medical Equipment

Drug Infusion Systems Market Forecast 2026–2030: Market Size, Trends And Growth Opportunities

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Drug Infusion Systems Market Forecast: What Value Will The Market Reach By 2030?

The drug infusion systems market has experienced significant expansion in recent years. It is forecast to grow from $14.23 billion in 2025 to $15.51 billion in 2026, at a compound annual growth rate (CAGR) of 9.0%. This past growth can be ascribed to elements such as an uptick in hospitalization rates, the increasing prevalence of chronic conditions, the expansion of oncology and chemotherapy interventions, the rising application of intravenous drug delivery, and improved access to infusion technologies.

The drug infusion systems market size is projected to experience substantial growth in the upcoming years. It is set to expand to $22.23 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the forecast period stems from factors such as the increasing integration of connected infusion systems, a greater need for ambulatory and homecare infusion solutions, the broadening of precision drug delivery methods, an intensified emphasis on workflow automation within hospitals, and amplified investments in intelligent healthcare infrastructure. Key trends observed throughout the forecast period encompass a surge in the embrace of smart infusion pumps, increased incorporation of dose error reduction systems, wider utilization of multi-channel infusion devices, the proliferation of home-based infusion therapies, and a heightened emphasis on features designed for patient safety.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=51795851&type=smp&name=Drug%20Infusion%20Systems%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Drug Infusion Systems Market Growth Factors Behind Sustained Expansion

Increasing healthcare expenditure is anticipated to boost the expansion of the drug infusion systems market in the future. Healthcare expenditure represents the overall sum allocated to healthcare products and services within a specific timeframe, usually a year. With a rise in healthcare spending, medical facilities such as hospitals and clinics acquire greater funds to invest in sophisticated drug infusion systems, consequently driving up the demand for these products. An example illustrating this trend is data from May 2024, where reports from the Office for National Statistics (ONS), a UK national statistical institute, indicated that total healthcare spending increased by 5.6% in nominal terms between 2022 and 2023, a significant jump from the 0.9% growth rate seen in 2022. Consequently, the expanding healthcare expenditure is projected to fuel the advancement of the drug infusion systems market.

Drug Infusion Systems Market Segment Analysis Spotlighting Growth Areas

The drug infusion systems market covered in this report is segmented –

1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

Subsegments:

1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

Drug Infusion Systems Market Industry Trends Fueling Future Revenue Growth

Major companies in the drug infusion systems market are advancing technology, such as cloud-based infusion management systems, to enhance patient care, improve accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that facilitate the monitoring, administration, and tracking of medication infusions via the cloud. For instance, in June 2023, Eitan Medical, a US-based global leader in advanced infusion therapy and drug delivery solutions, introduced Eitan Insights, a new cloud-based infusion management system specifically designed for the unique demands of home and specialty infusions. Eitan Insights is engineered to provide healthcare professionals with real-time data and analytics, enabling them to remotely oversee patients and modify treatment plans as necessary. This system improves medication safety by decreasing the likelihood of errors and enhancing adherence to prescribed protocols.

Drug Infusion Systems Market Leading Players And Competitive Positioning

Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited

View The Full Drug Infusion Systems Market Report:

https://thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Drug Infusion Systems Market Regional Distribution: Which Areas Power Market Growth?

North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *